RxSight, Inc. (RXST) Tops Q2 EPS by 22c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
RxSight Inc. (RXST) PT Lowered to $65 at Stifel
August 6, 2024 5:17 AM EDTStifel analyst Tom Stephan lowered the price target on RxSight Inc. (NASDAQ: RXST) to $65.00 (from $70.00) while maintaining a Buy rating.
The analyst comments "RXST shares should snap back from an inexplicably-pronounced intra-quarter sell-off--likely exasperated by a difficult med-tech tape--following a strong beat-and-raise. While... More
RxSight Inc. (RXST) PT Lowered to $59 at BTIG
August 6, 2024 4:57 AM EDTBTIG analyst Ryan Zimmerman lowered the price target on RxSight Inc. (NASDAQ: RXST) to $59.00 (from $73.00) while maintaining a Buy rating.
The analyst comments "We reiterate our Buy and adjust our PT to $59 (from $73) following 2Q24 results. RXST continues to deliver strong FY24 results with 2Q24 revenue of $34.9M (67.6% Y/Y) and adj. LPS of $0.00 above BTIG/Consensus ests. of $32.2M/$32.3M and adj. LPS of... More
